Observational studySurgical endoscopy2022
Endoscopic subserosal dissection for gastric tumors: 18 cases in a single center.
Observational study in Surgical endoscopy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Natural History of Gastric Subepithelial Lesions Measuring 1 to 2 cm.The Korean journal of helicobacter and upper gastrointestinal research · 2026Article
- Clinical efficacy of endoscopic resection for subepithelial tumors in the esophagogastric junction and gastric cardia: an observational study.Clinical endoscopy · 2026Article
- Nationwide Multicenter Study of Advanced Endoscopic Resection and Malignant Risk Model for Gastric Myogenic Tumors (GASTRO Trial).Life (Basel, Switzerland) · 2026Article
- Dental-floss traction-assisted endoscopic full-thickness resection of a gastrointestinal exophytic tumor: A case report.SAGE open medical case reports · 2026Article
- Efficacy and safety of endoscopic subserosal dissection treatment for gastrointetinal submucosal tumors in the upper gastrointestinal tract.BMC surgery · 2024Article
- Prevalence and natural course of incidental gastric subepithelial tumors.Clinical endoscopy · 2024Article
- Endoscopic resection penetrating the muscularis propria for gastric gastrointestinal stromal tumors: advances and challenges.Clinical endoscopy · 2024Article
- Laparoscopic resection for gastric schwannoma larger than 30 mm with long-term outcomes.BMC surgery · 2023Article
- Getting the gist of GI stromal tumors: diving deeper than endoscopic submucosal dissection.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2023Article
- Endoscopic adventitial dissection of a rectal GI stromal cell tumor.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndoscopic submucosal dissection has technical limitations for the resection of gastric epithelial tumors with severe fibrosis and mixed or exophytic gastric subepithelial tumors (SETs).
aimsTo analyze the safety and effectiveness of endoscopic subserosal dissection (ESSD) for tumors growing in the subserosal space.
methodsThis observation study enrolled 18 patients who were diagnosed with gastric tumors and underwent ESSD at the Presbyterian Medical Center from 2010 to March 2019.
resultsA total of 18 patients were treated by ESSD. The mean age of the patients was 61.7 years. The mean length of the long axis of the tumor was 18.0 ± 5.0 mm. The mean operation time was 44 (range 11-167) min. The pathologic diagnosis was leiomyoma in nine cases (50.0%), gastrointestinal stromal tumor in six (33.3%), low-grade adenoma with severe fibrosis in two (11.1%), and schwannoma in one (5.6%). There were three cases of perforation, which were treated conservatively. The complete resection rate was 94%, and local or systemic tumor recurrence was not seen in a mean 70 months of follow-up.
conclusionESSD can be used for epithelial tumors with severe fibrosis and mixed or exophytic gastric SETs in the lesser curvature, cardia, or fundus that cannot be treated using standard methods.
Indexed as
Identifiers
35441314What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.